This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Sanofi Pasteur Inc.
Sanofi Pasteur Inc., a leading global player in the vaccine industry, is headquartered in the United States and operates extensively across North America and beyond. Founded in 2004, the company has established itself as a key subsidiary of Sanofi, focusing on the research, development, and production of innovative vaccines that protect against infectious diseases. With a diverse portfolio that includes vaccines for influenza, meningitis, and polio, Sanofi Pasteur is renowned for its commitment to public health and safety. The company’s unique approach combines cutting-edge technology with rigorous scientific research, ensuring high-quality products that meet the evolving needs of healthcare providers and patients alike. Recognised for its significant contributions to immunisation efforts worldwide, Sanofi Pasteur holds a prominent market position, continually striving to enhance vaccine accessibility and effectiveness.
DitchCarbon Score
How does Sanofi Pasteur Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sanofi Pasteur Inc.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sanofi Pasteur Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of Sanofi, it inherits climate commitments and reduction targets from its parent company. Sanofi has engaged in various initiatives aimed at reducing carbon emissions, including participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, which focuses on transitioning to 100% renewable energy. While specific reduction targets for Sanofi Pasteur Inc. are not detailed, the overarching commitments from Sanofi indicate a strong focus on sustainability and climate action. The company is actively working towards significant emissions reductions across its operations, aligning with industry standards and best practices in climate management. As of now, there are no reported achievements or specific numbers related to emissions reductions for Sanofi Pasteur Inc. However, the commitment to sustainability and climate initiatives reflects a proactive approach to addressing climate change within the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 545,114,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 677,549,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sanofi Pasteur Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
